Las Vegas, NV -- (SBWIRE) -- 12/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Zogenix, Inc. (NASDAQ:ZGNX), Crocs, Inc. (NASDAQ:CROX), Lannett Company, Inc. (NYSEMKT:LCI), TASER International, Inc. (NASDAQ:TASR)
Zogenix, Inc. (NASDAQ:ZGNX) managed to keep its fall at -1.23% on below -normal volume of 1.60M shares. The stock settled at $3.20 after floating in a range of $3.18 to $3.33. Its latest price has reached market capitalization of $344.94 million. Its 52-week range has been $1.11 to $3.45. Zogenix, Inc. (Zogenix) is a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain. The Company’s product Sumavel DosePro offers needle-free subcutaneous administration of sumatriptan for the treatment of migraine and cluster headache in a pre-filled, single-use delivery system. Its lead product candidate.
Has ZGNX Found The Bottom and Ready To Move Up? Find Out Here
Crocs, Inc. (NASDAQ:CROX) traded down on a volume of 1.60 million, lower than its standard daily volume. Shares have dropped-0.37% to $13.51. Over the last twelve months, the stock has gained 1.2% and faced a worst price of $11.96. Crocs, Inc is a designer, manufacturer and distributor of footwear and accessories for men, women and children. As of December 31, 2012, the Company sold its products in more than 90 countries through domestic and international retailers and distributors and directly to end-user consumers through its Company-operated retail stores, outlets, kiosks and Webstores. Its footwear products are divided into four product offerings.
Has CROX Found The Bottom And Ready To Gain Momentum? Find Out Here
Lannett Company, Inc. (NYSEMKT:LCI) settled -0.97% lower at $31.79 on above-normal volume of 1.61M shares during the last trading day. The stock has its 12-month high at $33.10 and 52-week low price was $4.75. It traded in a range of $30.26 to $33.10 during the last trading day. Lannett Company, Inc. is engaged in developing, manufacturing, marketing and distributing generic versions of branded pharmaceutical products. All of the Company’s products manufactured and/or sold are prescription products. The Company’s products containing Levo are produced and marketed with 12 varying potencies. In addition to generic Levo tablets, the Company also markets and distributes Unithroid tablets, a branded version of Levo, which is produced and marketed with 11 varying potencies.
Will LCI Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, TASER International, Inc. (NASDAQ:TASR) was down on high volume, trading at a volume of 1.59M versus its average daily volume of 1.45 million shares. At $16.18, the stock has attained market capitalization of 839.15 million. TASER International, Inc. (TASER) is engaged in development, manufacture and sale of electronic control devices (ECDs) designed for use in the law enforcement, military, corrections, private security and personal defense markets. Federal, state and local law enforcement agencies in the United States and globally represent the target market for its TASER ECDs. Its TASER devices are deployed in county correctional facilities, such as those operated by the Los Angeles Custody Division and the Maricopa County Sheriff’s Office (AZ). TASER devices deployed in support of strategic military operations in locations globally.
Why Should Investors Buy TASR After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)